GlassScriptPhysician profile
Ara Nason Bush
NPI 1386959336
$18,303.44
in general payments reported to CMS, 2019-2025
29 companies · $2,016 in 2025
The $2,016 reported for 2025 was more than what 82% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,401 · 2020: $348 · 2021: $2,477 · 2022: $3,596 · 2023: $599 · 2024: $867 · 2025: $2,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,482.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $4,966.57 | 2019-2024 | |
| Trimed, INC. | $4,097.83 | 2019-2025 | |
| Arthrex, INC. | $2,861.11 | 2019 | |
| Endo Pharmaceuticals INC. | $1,437.31 | 2019-2024 | Xiaflex |
| Axogen | $1,103.66 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Alafair Biosciences, INC. | $737.70 | 2022-2025 | Versawrap |
| Stryker Corporation | $577.70 | 2019-2025 | T2 Alpha, Fixos, Bio4 |
| Skeletal Dynamics INC | $477.25 | 2021-2024 | Geminus, Implate, Ijs |
| Amgen INC. | $334.00 | 2024-2025 | Krystexxa, Evenity |
| Endo USA, INC. | $328.44 | 2024-2025 | Xiaflex |
| Integra Lifesciences Corporation | $283.43 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $161.06 | 2025 | |
| Smith+Nephew, INC. | $115.09 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $114.63 | 2022 | |
| Depuy Synthes Sales INC. | $108.33 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $96.70 | 2024-2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $83.26 | 2022-2023 | Krystexxa |
| Tela Bio, INC. | $81.68 | 2021 | |
| Medshape, INC. | $75.00 | 2023 | Dynanail |
| Globus Medical, INC. | $50.79 | 2019 | |
| Polynovo North America LLC | $45.38 | 2025 | Novosorb Btm |
| Boston Scientific Corporation | $38.37 | 2022-2024 | |
| Convatec INC. | $32.42 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $22.79 | 2025 | |
| Bioventus LLC | $17.86 | 2022 | |
| Acumed LLC | $15.71 | 2025 | Innate Implant |
| Osiris Therapeutics INC. | $15.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.97 | 2022 | |
| Anika Therapeutics, INC. | $11.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ara Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.